Navigation Links
Come Visit Visikol at Society of Toxicology 2019 in Baltimore at Booth 3225
Date:2/14/2019

This year’s conference in Baltimore will bring together over 315 companies from around-the-world and will host 80 scientific sessions and 2,100 presentations. Given SOT’s mission to bring together researchers from all facets of the toxicology research space, Visikol will feature its OpenLiver™ 3D cell culture model initiative that it recently launched with Biopredic International. As a leader in 3D cell culture assays, Visikol has launched the OpenLiver initiative to provide researchers with access to open source liver 3D cell culture models of varying complexities such that consensus surrounding appropriate model choice for evaluating mechanisms of toxicity and studying liver-related diseases (e.g. NASH, NAFLD) may be generated.

“By offering all the culture protocols and material sourcing information for our models through this OpenLiver initiative, we hope to enable researchers across the pharmaceutical and biotech community to more easily compare results within and between labs. We want to get everyone on the same page with the types of models that are being used for disease modeling and liver toxicity questions so that multiple labs can compare results and the field can establish consensus,” described Visikol Director of In Vitro Studies Dr. Erin Edwards. During the conference, Visikol we be hosting a talk by Chief Science Officer Dr. Thomas Villani titled Building Consensus in the Liver 3D Cell Culture Field Through Open Source Models. The talk will take place on 3/11 from 9-10:00 AM in room 339.

In this session, Visikol will discuss how it has developed open source liver 3D cell culture models for use in routine toxicity studies as well as more complex investigations into disease pathology, beginning with an in-depth discussion of the OpenLiver HepaRG™ NP 3D model. Additionally, participants will learn how cost, throughput, and in vivo relevancy can be optimized by varying the complexity of liver 3D cell culture models implemented.

Additionally, Visikol will be presenting a poster at SOT this year titled Complete Characterization of Cell Death in 3D Cell Culture Models for Toxicity Profiling (3074/ P611) on 3/13. To discuss your next research project, stop by booth 3225.

About Visikol
Visikol is a CRO focused on advanced drug discovery that is leading the fields of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects. Visikol offers a portfolio of drug discovery services ranging from 2D and 3D cell culture model and assay development to in vitro screening, animal tissue histology and automated image processing. The focus of these services is to transform tissues into images and ultimately into quantitative data sets that can be mined for actionable insights that help our Clients make more informed decisions during the drug discovery process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit our website at visikol.com.

Read the full story at https://www.prweb.com/releases/come_visit_visikol_at_society_of_toxicology_2019_in_baltimore_at_booth_3225/prweb16099929.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Getting rid of unwanted visitors
2. Uganda Heart Institute physicians and nurses visit Texas Childrens Heart Center
3. ACC Mascots Visit Patients at Brenner Childrens Hospital
4. Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation
5. Rep. Honda to Visit Crossmatch in Redwood City
6. Acuant Partners with RightCrowd to Extend Visitor Management Solution
7. German Chancellor Visits DERMALOG
8. Come Visit Visikol at SLAS to Learn About 3D Cell Culture Assays and Models
9. Visikol Co-Founder Michael Johnson named to 2017 Forbes 30 Under 30 List
10. Visikol Hits Key Milestone, Recognized by Forbes for Passion & Innovation
11. Visikol Appoints Pharmaceutical Industry Leader, Stewart Hunt, as Director of US Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2020)... ... May 26, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., a clinical-stage ... bispecific T cell engagers and TCR-based therapeutics, has implemented Genedata Biologics ...
(Date:5/21/2020)... ... May 20, 2020 , ... Catalent, the leading ... cell and gene therapies, and consumer health products, today announced that Jean-François Chaubard, ... at the ISCT 2020 Paris Virtual conference, which takes place on 28 – ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... accurately and easily project contracted liabilities with payers, providers and pharmacies – ... discounts/rebates to Commercial and Government entities, Copay and Patient Assistance Program liabilities ...
Breaking Biology News(10 mins):
(Date:4/18/2020)... ... April 17, 2020 , ... ... Small Business Innovation Research (SBIR) program to support the expansion of its digital ... the NSF, which conducts a rigorous merit-based review process, adds to NeuroFlow’s ...
(Date:4/7/2020)... , ... April 06, 2020 , ... ... solutions for the life sciences industry, has announced the release of at-home virtual ... our top priority is the health and safety of our employees as we ...
(Date:4/1/2020)... ... March 30, 2020 , ... A joint venture between mobile ... earlier this year to bring telehealth to various government agencies, has now focused ... officials are currently?awaiting an Emergency Use Authorization (EUA) waiver from the FDA?to?perform?AI?testing in ...
(Date:4/1/2020)... , ... March 31, 2020 , ... Carterra® Inc., the ... Immunology (LJI), announced today that they will use Carterra’s proprietary LSA™ platform to screen ... to the clinic as early as this summer. , La Jolla Institute for ...
Breaking Biology Technology: